Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

192.55B

Market cap192.55B

Price-Earnings ratio

10.06

Price-Earnings ratio10.06

Dividend yield

2.87%

Dividend yield2.87%

Average volume

11.93M

Average volume11.93M

High today

$42.96

High today$42.96

Low today

$42.68

Low today$42.68

Open price

$43.50

Open price$43.50

Volume

147.67K

Volume147.67K

52 Week high

$81.44

52 Week high$81.44

52 Week low

$35.12

52 Week low$35.12

NVO News

Simply Wall St 43m

Novo Nordisk Trial Updates Test Support For Obesity And Diabetes Valuation

Novo Nordisk (NYSE:NVO) is set to present new clinical data from its cardiometabolic portfolio at the 2026 American Diabetes Association Scientific Sessions. K...

Reuters 2h

Focus: GLP-1 drugs may have a beneficial effect across many types of cancer - Reuters

...

Reuters 4h

Novo Nordisk launches Wegovy in UAE - Reuters

...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

The Wall Street Journal 5h

Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE

The Emirates Drug Establishment said this week that it had approved Novo Nordisk's once-daily tablet. Novo Nordisk Novo Nordisk NOVO.B -2.54 %decrease; red dow...

Nasdaq 21h

Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down

Key Points VK2735 is being developed in both subcutaneous and oral forms, and upcoming Phase 1 maintenance trial results are a major catalyst. VK2735 may offe...

The Motley Fool 2d

Lexicon Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Director — Dr. Mike Exton Senior Vice Presid...

TipRanks 2d

Novo Nordisk Details Progress of 2026 Share Buyback Programme

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Nasdaq 2d

Is Eli Lilly Starting an Nvidia-Style Run?

Key Points Eli Lilly recently won approval of a new product, strengthening its weight loss portfolio. The pharma giant has become the leader in the U.S. GLP-1...

Simply Wall St 4d

Assessing Novo Nordisk Valuation After Mixed Returns And Earnings Snapshot

Advertisement Why Novo Nordisk (NYSE:NVO) Is Back On Investors’ Radar Novo Nordisk (NYSE:NVO) has drawn attention recently after its stock moved alongside rep...

The Motley Fool 4d

Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors

The big news in the GLP-1 weight loss drug space right now is the introduction of pills. That seems to have broadened the appeal of GLP-1s, as many consumers si...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.